Note: Aviceda Therapeutics's revenues are gauged from an analysis of company filings.
Aviceda Therapeutics's Income Statement (based on Industry Averages)
Aviceda Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Aviceda Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 31, 2024
18
68%
$28 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Aviceda Therapeutics is developing and marketing.
Aviceda Therapeutics doesn't have any recent trademark applications, indicating Aviceda Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
AVICEDA THERAPEUTICS Research and development in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; clinical trials in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; providing a website with information on medical research in the fields of ocular degenerative, inflammatory, and fibrotic diseases via the Internet
06/14/2019
A Research and development in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; clinical trials in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; providing a website with information on medical research in the fields of ocular degenerative, inflammatory, and fibrotic diseases via the Internet
06/14/2019
See all trademarks and details in the Full Report.
Market Share of Aviceda Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Aviceda Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Aviceda Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Aviceda Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
